Abstract

Thrombin, the ligand of the protease-activated receptor 1 (PAR1), is a well-known stimulator of proangiogenic responses in vascular endothelial cells (ECs), which are mediated through the induction of vascular endothelial growth factor (VEGF). However, the transcriptional events underlying this thrombin-induced VEGF induction and angiogenic response are less well understood at present. As reported here, we conducted detailed promotor activation and signal transduction pathway studies in human microvascular ECs, to decipher the transcription factors and the intracellular signaling events underlying the thrombin and PAR-1-induced endothelial VEGF induction. We found that c-FOS is a key transcription factor controlling thrombin-induced EC VEGF synthesis and angiogenesis. Upon the binding and internalization of its G-protein-coupled PAR-1 receptor, thrombin triggers ERK1/2 signaling and activation of the nuclear AP-1/c-FOS transcription factor complex, which then leads to VEGF transcription, extracellular secretion, and concomitant proangiogenic responses of ECs. In conclusion, exposure of human microvascular ECs to thrombin triggers signaling through the PAR-1–ERK1/2–AP-1/c-FOS axis to control VEGF gene transcription and VEGF-induced angiogenesis. These observations offer a greater understanding of endothelial responses to thromboinflammation, which may help to interpret the results of clinical trials tackling the conditions associated with endothelial injury and thrombosis.

Highlights

  • Cardiovascular diseases (CVDs) are a leading cause of death worldwide [1,2]

  • Dose–Response Effect of Thrombin on endothelial cells (ECs) Angiogenesis and vascular endothelial growth factor (VEGF) Production In prior studies, we employed in vitro endothelial tube formation assays to study angiogenic properties of ECs and mesenchymal stromal cells (MSCs) [42,43], and a similar setup was chosen in this study

  • Since VEGF is a main regulator of endothelial angiogenesis, we examined the effect of thrombin on VEGF production by ECs

Read more

Summary

Introduction

Cardiovascular diseases (CVDs) are a leading cause of death worldwide [1,2]. Endothelial cell (EC) dysfunction is a critical stage in the development of many CVDs [3]. Several acute and chronic pathologies can promote EC dysfunction and predispose the interface to a prothrombotic state [5,6]. The inflammation that is associated with these conditions can promote EC activation and expression of highly procoagulant tissue factor (TF/CD142) [7,8,9], thereby promoting thromboinflammation and the generation of thrombin (Figure 1A). The generation of thrombin in the vicinity of ECs leads to endothelial activation and the release of vascular endothelial growth factor (VEGF) to stimulate endothelial repair

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call